NCT00312091View on ClinicalTrials.gov

Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
HIV Infections
Interventions
DRUG

Lamivudine, nevirapine, and stavudine fixed-dose tablet

7 mg d4T, 30 mg 3TC, 50 mg NVP tablet

DRUG

Lamivudine

Dosage dependent on weight. More information on this criterion can be found in the protocol.

DRUG

Nevirapine

Dosage dependent on weight. More information on this criterion can be found in the protocol.

DRUG

Stavudine

Dosage dependent on weight. More information on this criterion can be found in the protocol.

Trial Locations (4)

10400

Queen Sirikit National Institute of Child Health, Pediatric Infectious Unit, Bangkok

10700

Siriraj Hospital Mahidol University CRS, Bangkok

50200

Chiang Mai University Pediatrics-Obstetrics CRS, Chiang Mai

20000 TH

Chonburi Hosp. CRS, Chonburri

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

International Maternal Pediatric Adolescent AIDS Clinical Trials Group

NETWORK

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00312091 - Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children | Biotech Hunter | Biotech Hunter